Advagen Pharma Limited voluntarily recalled Metoprolol Tartrate Tablets, USP, 50 mg due to the presence of foreign tablets or capsules. The Food and Drug Administration announced the Class II recall on Oct. 27, 2026.
How to tell if you have it
- Brand: Advagen Pharma
- Product: Metoprolol Tartrate Tablets 50 mg
- NDC: 72888-210-00
- Batch#: 2611C065A1
- Expiry: 05/2028
- Quantity: 3,684 bottles
The hazard
The recall addresses the presence of foreign tablets or capsules in the Metoprolol Tartrate Tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show other recent recalls of similar products include Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants (2026-09-29) and Novadoz Recalls Atorvastatin 40mg Due to Foreign Tablets (2026-10-21). American Health Packaging also recalled Metoclopramide Tablets due to foreign drug presence on Oct. 6, 2026.